1. Market Research
  2. > Cancer Industry

Colorectal Cancer Industry, September 2016 Market Reports from Top Publishers

You might be interested in: Therapy, Cancer, Diagnostics, Cancer Diagnostic, Biopsy, Molecular Diagnostic, Pharmaceutical, Antigen, Endoscope, Biosimilar, Cloud Computing, DNA, Infectious Disease, Oncology, Point Of Care Testing, Vaccine.


 
1-10 of 70 reports for Colorectal Cancer

Purchase Reports From Reputable Market Research Publishers

Molecular Diagnostics Market (By Application, Technology, Region and Companies) and Forecast to 2021 - Global Analysis

Molecular Diagnostics Market (By Application, Technology, Region and Companies) and Forecast to 2021 - Global Analysis

  • $ 1 100
  • Industry report
  • September 2016
  • by Igate Research

The molecular diagnostics market is one of the most rapidly growing segments of the in vitro diagnostics industry. Molecular diagnostics is a new class of diagnostic tests that identify molecular and genetic ...

Global Colorectal Cancer Partnering 2010 to 2016

Global Colorectal Cancer Partnering 2010 to 2016

  • $ 1 495
  • Industry report
  • September 2016
  • by Currentpartnering

The Global Therapy Partnering Terms and Agreements since 2010 report provides understanding and access to partnering deals and agreements entered into by the world’s leading healthcare companies. • ...

Metastatic Colorectal Cancer-Global API Manufacturers, Marketed and Phase III Drugs Landscape, 2016

Metastatic Colorectal Cancer-Global API Manufacturers, Marketed and Phase III Drugs Landscape, 2016

  • $ 2 000
  • Industry report
  • September 2016
  • by Delve Insight

SUMMARY DelveInsight’s Report, “Metastatic Colorectal Cancer-Global API Manufacturers, Marketed and Phase III Drugs Landscape, 2016”, provides comprehensive insights about the marketed drugs, drug ...

Colorectal Cancer-Global API Manufacturers, Marketed and Phase III Drugs Landscape, 2016

Colorectal Cancer-Global API Manufacturers, Marketed and Phase III Drugs Landscape, 2016

  • $ 2 000
  • Industry report
  • September 2016
  • by Delve Insight

SUMMARY DelveInsight’s Report, “Colorectal Cancer-Global API Manufacturers, Marketed and Phase III Drugs Landscape, 2016”, provides comprehensive insights about the marketed drugs, drug sales, Phase ...

Colorectal Cancer: Analytical Tool

Colorectal Cancer: Analytical Tool

  • $ 7 125
  • Industry report
  • August 2016
  • by Bioseeker

Analytical Tools are cancer area specific intelligence and surveillance toolkits within a select number of hot, emerging cancer therapy areas. They are designed to empower biotech/pharma professionals ...

Target Atlas in Colorectal Cancer: A Competitive Outlook

Target Atlas in Colorectal Cancer: A Competitive Outlook

  • $ 2 700
  • Industry report
  • August 2016
  • by Bioseeker

Extra value: One year of free online updates included with this product "Target Atlas in Colorectal Cancer: A Competitive Outlook" helps you to understand the complex world of commercial development in ...

Colorectal Cancer Drug Pathway Analyzer

Colorectal Cancer Drug Pathway Analyzer

  • $ 2 700
  • Industry report
  • August 2016
  • by Bioseeker

Extra value: One year of free online updates included with this product There are today at least 516 targeted molecular therapies known to affect more than 252 specific intracellular signaling pathways ...

Colorectal Cancer Diagnostic Tests - Medical Devices Pipeline Assessment, 2016

Colorectal Cancer Diagnostic Tests - Medical Devices Pipeline Assessment, 2016

  • $ 4 000
  • Industry report
  • August 2016
  • by Global Data

Colorectal Cancer Diagnostic Tests - Medical Devices Pipeline Assessment, 2016 Summary GlobalData's Medical Devices sector report, “Colorectal Cancer Diagnostic Tests - Medical Devices Pipeline Assessment, ...

Colorectal Cancer Drug Pipeline Update

Colorectal Cancer Drug Pipeline Update

  • $ 2 700
  • Company report
  • August 2016
  • by Bioseeker

Until a decade ago, 5FU/leucovorin formed the mainstay of colorectal cancer treatment but Camptosar and Eloxatin quickly established themselves as components of gold-standard therapy. The advent of Avastin ...

Colorectal Cancer - Patent Overview in the years 2011 - 2016

Colorectal Cancer - Patent Overview in the years 2011 - 2016

  • $ 500
  • Industry report
  • August 2016
  • by Mordor Intelligence LLP

Colorectal cancer is the manifestation of Cancer from colon or rectum. It has been found that most colorectal cancers happen in old age and lifestyle factors with only a small number of cases due to genetic ...

About 6 300 reports for Colorectal Cancer

Download Unlimited Documents from Trusted Public Sources

Therapy Market in the US

  • January 2014
    122 pages
  • Therapy  

    Cancer  

    Chemotherapy  

  • United States  

View report >

ReportLinker simplifies how Analysts and Decision Makers get industry data for their business.